Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys ; day:17 ; month:6 ; year:2024 ; pages:1-8
Psychopharmacology ; (17.6.2024), 1-8
- Urheber
-
Fink-Jensen, Anders
Wörtwein, Gitta
Klausen, Mette Kruse
Holst, Jens Juul
Hartmann, Bolette
Thomsen, Morgan
Ptito, Maurice
Beierschmitt, Amy
Palmour, Roberta M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-024-06637-2
- URN
-
urn:nbn:de:101:1-2408271239260.169801078732
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fink-Jensen, Anders
- Wörtwein, Gitta
- Klausen, Mette Kruse
- Holst, Jens Juul
- Hartmann, Bolette
- Thomsen, Morgan
- Ptito, Maurice
- Beierschmitt, Amy
- Palmour, Roberta M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation
Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Alcohol
Alcohol
Alcohol
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation
Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Alcohol
Alcohol
Alcohol
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation
Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Alcohol
Alcohol